 NEW YORK, July 12, 2021 PRNewswire -- Immunic, Inc. Nasdaq: IMUX, a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced that it will host a virtual RD Day today at 4:00 pm ET. Immunics management and Zuoming Sun, Ph.D. 